Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Scientists have discovered the protective role of a bacterium that could prevent long Covid. Their discovery could lead to the development of new therapy approaches.
Coronaviruses can generate new variants capable of infecting humans after circulating in animal reservoirs. Researchers develop broad-spectrum antiviral drugs to curb the spread of these pathogens.
Vaccination against human papillomavirus (HPV) reduces the risk of cervical cancer for at least 18 years, according to a new study. There were no signs of waning protection over time.
A new study into the long-term health impacts of coronavirus has found changes in the blood after Covid-19 that might pinpoint patients at risk of ongoing lung disease.
Researchers have uncovered how a high-risk class of genetic vectors can efficiently spread antibiotic resistance within the gut, enabling even highly virulent bacteria to acquire drug resistance.
Should younger and older people receive different treatments for the same infection? New research suggests that age-specific treatments may be necessary in ongoing antibiotic resistance crisis.
With antimicrobial resistance causing over 5 million deaths annually, rapid outbreak detection is critical. A German lab demonstrates how FTIR spectroscopy can transform hospital infection control.
Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.
New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).
In an epidemic setting, even a small proportion of citizens who do not follow public health measures can amplify the spread of contagions and make them expand faster, a new study reveals.
Researchers from Osaka have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.
In response to rising H5N1 avian influenza cases in Europe, a new framework aims to help countries detect and respond to spillover to humans – from enhanced surveillance to pandemic preparedness.
From volcanic activity to the deaths of millions: Using climate data and documentary evidence, researchers have painted a detailed picture of how the Black Death pandemic reached Europe.
Climate change, poverty, and drug resistance are combining to create an escalating health crisis that could become a ‘creeping catastrophe’ if left unaddressed, a new international study finds.
Pseudomonas aeruginosa, a hospital-acquired bacterium that causes serious infections, can move from the lungs to the gut inside the same patient, raising the risk of sepsis, new research reveals.
Europe’s healthcare systems face growing pressure: fewer staff, higher infection-control demands, and increased documentation. Estonia is already built for this. With 99% of health data digital, digital trust is built into everyday healthcare – giving Estonian companies a strong foundation for efficient collaboration, fast traceability, and AI-supported operations.
More than a decade of protection against the human papillomavirus (HPV): a new study confirms the long-term effectiveness of the HPV vaccine to prevent development of cervical cancer and pre-cancer.
An innovative Group A Streptococcus “One-Step Antigen Extraction + Detection” Kit (immunochromatography), developed by GenSure Biotech Inc., has successfully obtained both Class B and Class C EU IVDR certifications for in vitro diagnostic medical devices.
